财报披露
PolyPid(PYPD)07-03 04:55
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-058655 Act: 34 Size: 190 KB 网页链接
简介：PolyPid Ltd.是根据以色列法律注册成立，并于2008年2月28日开始运作。该公司是一家3期临床阶段的生物制药公司，专注于利用专有的PLEX技术开发靶向、局部给药和缓释疗法。该公司的候选产品旨在通过将PLEX技术与已获FDA批准的药物或创新候选药物配对，以达到新的治疗效果，从而解决具有高度未满足医疗需求的疾病。
| 今开：3.71 | 昨收：3.65 |
| 最高：3.816 | 最低：3.7 |
| 涨停价： | 跌停价： |
| 总市值：18037668 |
PolyPid(PYPD)07-03 04:55
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-058655 Act: 34 Size: 190 KB 网页链接
PolyPid(PYPD)05-29 04:15
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-047069 Act: 34 Size: 166 KB 网页链接
PolyPid(PYPD)06-18 20:15
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-053533 Act: 34 Size: 34 KB 网页链接
PolyPid(PYPD)07-15 18:15
$PolyPid(PYPD)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-002154 Act: 33 Size: 1 KB 网页链接
PolyPid(PYPD)05-08 19:15
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-040629 Act: 34 Size: 98 KB 网页链接
PolyPid(PYPD)07-03 04:15
$PolyPid(PYPD)$ F-3 Registration statement by foreign private issuers Accession Number: 0001213900-24-058595 Act: 33 Size: 313 KB 网页链接
PolyPid(PYPD)04-30 20:25
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-037474 Act: 34 Size: 29 KB 网页链接
PolyPid(PYPD)05-18 04:05
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-044726 Act: 34 Size: 199 KB 网页链接
PolyPid(PYPD)07-03 04:15
$PolyPid(PYPD)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001213900-24-058604 Act: 33 Size: 97 KB 网页链接
产业链观察2022-09-02 21:42
药闻| $PolyPid(PYPD)$ 宣布D-PLEX₁₀₀预防腹部手术部位感染的3期SHIELD I试验的最高结果。研究没有达到降低手术部位感染和死亡率的主要终点。查看全文
$PolyPid(PYPD)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-002154 Act: 33 Size: 1 KB 网页链接
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-058655 Act: 34 Size: 190 KB 网页链接
$PolyPid(PYPD)$ F-3 Registration statement by foreign private issuers Accession Number: 0001213900-24-058595 Act: 33 Size: 313 KB 网页链接
$PolyPid(PYPD)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001213900-24-058604 Act: 33 Size: 97 KB 网页链接
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-053533 Act: 34 Size: 34 KB 网页链接
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-047069 Act: 34 Size: 166 KB 网页链接
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-044726 Act: 34 Size: 199 KB 网页链接
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-040629 Act: 34 Size: 98 KB 网页链接
$PolyPid(PYPD)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-24-037474 Act: 34 Size: 29 KB 网页链接
$PolyPid(PYPD)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-24-033795 Act: 34 Size: 46 KB 网页链接